QQ客服 官方微博 反馈留言

浏览/检索结果: 共112条，第1-10条 帮助 限定条件 发表日期：2017    专题：山东大学    第一署名单位    第一作者单位    通讯作者单位     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Diagnostic and prognostic value of blood samples for KRAS mutation identification in lung cancer: a meta-analysis 期刊论文 ONCOTARGET, 2017, 卷号: 8, 期号: 22, 页码: 36812-36823 作者:  Shen, Hongchang;  Che, Keying;  Cong, Lei;  Dong, Wei;  Zhang, Tiehong 收藏  |  浏览/下载：4/0  |  提交时间：2019/12/16 lung cancer  blood  KRAS  diagnostic test  predictive factor   Appropriate surgical modalities for stages T2a and T2b in the eighth TNM classification of lung cancer 期刊论文 SCIENTIFIC REPORTS, 2017, 卷号: 7 作者:  Bie, Fenglong;  Qu, Xiao;  Yang, Xudong;  Pang, Zhaofei;  Yang, Yufan 收藏  |  浏览/下载：12/0  |  提交时间：2019/12/16 Differential effects on lung and bone metastasis of breast cancer by Wnt signalling inhibitor DKK1. 期刊论文 Nature cell biology, 2017, 卷号: 19, 期号: 10 作者:  Zhuang, Xueqian;  Zhang, Hao;  Li, Xiaoyan;  Li, Xiaoxun;  Cong, Min 收藏  |  浏览/下载：3/0  |  提交时间：2019/12/16 [Retracted] Efficacy of dual-functional liposomes containing paclitaxel for treatment of lung cancer. 期刊论文 Oncology reports, 2017, 卷号: 38, 期号: 5 作者:  Wang, Rong-Hua;  Cao, Hong-Mei;  Tian, Zhi-Ju;  Jin, Bo;  Wang, Qing 收藏  |  浏览/下载：2/0  |  提交时间：2019/12/16 Recent Development in the Discovery of Anaplastic Lymphoma Kinase (ALK) Inhibitors for Non-small Cell Lung Cancer 期刊论文 CURRENT MEDICINAL CHEMISTRY, 2017, 卷号: 24, 期号: 6, 页码: 590-613 作者:  Liu, Jingru;  Ma, Shutao 收藏  |  浏览/下载：2/0  |  提交时间：2019/12/16 ALK  NSCLC  inhibitors  point mutations  biological activity  SAR   Efficacy and safety of third-line treatment with anlotinib in patients with refractory advanced non-small-cell lung cancer (ALTER-0303): a randomised, double-blind, placebo-controlled phase 3 study 期刊论文 LANCET ONCOLOGY, 2017, 卷号: 18, 页码: S3-S3 作者:  Han, Baohui;  Li, Kai;  Wang, Qiming;  Zhao, Yizhuo;  Zhang, Li 收藏  |  浏览/下载：3/0  |  提交时间：2019/12/16 Current progress and outcomes of clinical trials on using epidermal growth factor receptor-tyrosine kinase inhibitor therapy in non-small cell lung cancer patients with brain metastases 期刊论文 慢性疾病与转化医学：英文版, 2017, 期号: 04 作者:  Ling-Ling Kong;  Lin-Lin Wang;  Li-Gang Xing;  Jin-Ming Yu 收藏  |  浏览/下载：7/0  |  提交时间：2019/12/11 Long-term outcomes of stage I NSCLC (<= 3 cm) patients following segmentectomy are equivalent to lobectomy under analogous extent of lymph node removal: a PSM based analysis 期刊论文 JOURNAL OF THORACIC DISEASE, 2017, 卷号: 9, 期号: 11, 页码: 4561-+ 作者:  Qu, Xiao;  Wang, Kai;  Zhang, Tiehong;  Shen, Hongchang;  Dong, Wei 收藏  |  浏览/下载：2/0  |  提交时间：2019/12/11 Segmentectomy  lobectomy  non-small cell lung cancer (NSCLC)  prognosis  lymph nodes (LN)   Microwave ablation combined with EGFR-TKIs versus only EGFR-TKIs in advanced NSCLC patients with EGFR-sensitive mutations 期刊论文 ONCOTARGET, 2017, 卷号: 8, 期号: 34, 页码: 56714-56725 作者:  Wei, Zhigang;  Ye, Xin;  Yang, Xia;  Zheng, Aimin;  Huang, Guanghui 收藏  |  浏览/下载：4/0  |  提交时间：2019/12/11 epidermal growth factor receptor  tyrosine kinase inhibitors  non-small  cell lung cancer  microwave ablation  progression free survival   Medication characteristics and regularities of TCM therapy for lung cancer based on data mining technology 期刊论文 Biomedical Research (India), 2017, 卷号: 28, 期号: 22, 页码: 10100-10104 作者:  Zhou W.;  Huang X.;  Zhang Y.;  Tian H. 收藏  |  浏览/下载：3/0  |  提交时间：2019/12/11 Data mining technology  Exploration on characteristics and regularities  Lung cancer  TCM therapy